Earnings Feed
Start Free
Gemini Therapeutics, Inc. /DE·4/A

Mar 9, 6:14 PM ET

Ong Tuyen 4/A

4/A · Gemini Therapeutics, Inc. /DE · Filed Mar 9, 2022

Insider Transaction Report

Form 4/AAmended
Period: 2021-10-04
Gemini Therapeutics, Inc. /DEGMTX
Ong Tuyen
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-10-04+15,528→ 15,528 total
    Exercise: $3.80Exp: 2031-10-03→ Common Stock (15,528 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.

Documents

2 files